Audible Premium Plus. $0.99/mo for the first 3 months + $20 Audible credits. 12 days only. Get this deal. Cancel anytime.

BioNTech's Richardson on Drug Pipeline
Oct 3 2024
Length: 38 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

BioNTech's Richardson on Drug Pipeline

Listen for free

View show details

Summary
BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who explains the company’s approach to drug development, hopes for drug launches and what sets it apart from rivals.
See omnystudio.com/listener for privacy information.

Show more Show less

Show more Show less

What listeners say about BioNTech's Richardson on Drug Pipeline

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon